Dysfunctional uterine bleeding: Difference between revisions

Line 41: Line 41:


[[Category:OBGYN]]
[[Category:OBGYN]]
   PMID: 29477633 DOI: 10.1016/j.contraception.2018.02.008
   [1] PMID: 29477633 DOI: 10.1016/j.contraception.2018.02.008

Revision as of 06:37, 26 April 2024

This diagnosis should be used only when all organic causes are ruled-out, which generally does not occur in the ED. See nonpregnant vaginal bleeding for the general approach.

Background

Vaginal bleeding definitions

  • Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals
  • Metrorrhagia: irregular vaginal bleeding outside the normal cycle
  • Menometrorrhagia: excessive irregular vaginal bleeding
  • Intermenstrual bleeding: variable amounts between regular menstrual periods
  • Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
  • Polymenorrhea: frequent and light bleeding
  • Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
  • Postmenopausal bleeding: recurrence of bleeding >6 mo after menopause
  • Amenorrhea: bleeding that is absent for > 6 months

Clinical Features

The patient will not report bleeding amounts in mL/day so knowing the capacities of products is useful:

  • One Light tampon holds ~3mL
  • One Super tampon holds ~10-12mL
  • One Maxi pad holds up to 25mL

Other symptoms related to anemia and hypovolemia should be noted. The patient may report cramping lower abdominal pain and back pain.

Differential Diagnosis

Nonpregnant Vaginal Bleeding

Systemic Causes

Reproductive Tract Causes

Evaluation

  • See nonpregnant vaginal bleeding for general approach
  • This diagnosis generally requires a endocervical curettage/endometrial biopsy to have been performed

Management

Heavy bleeding

  • Fluid administration
  • Estrogen-progestin OCP until gyn follow up - Preferred approach for most patients
  • Contraindications to Estrogen-progestin OCP:- Bulleted list item:Age greater than 35 years;Heavy tobacco use;Hypertension;History of CVA or ischemic heart disease;SLE;Migraines with Aura
  • TXA (Tranexamic acid) FDA approved for heavy menstrual bleeding. 1300mg (two 650mg tabs) po TID

Severe Bleeding

  • Maintain hemodynamics
  • Consider IV conjugated estrogen (Premarin) 25mg IV q4-6 hrs until bleeding stops
  • Continued severe bleeding requires D&C

See Also

External Links

References

 [1] PMID: 29477633 DOI: 10.1016/j.contraception.2018.02.008